SARM Investigational

Ligandrol (LGD-4033)

2,500 ฿ · 50 caps

What it is

Ligandrol (LGD-4033) is a SARM developed originally by Ligand Pharmaceuticals and currently held by Viking Therapeutics. Investigated in clinical trials for muscle wasting and age-related sarcopenia.

Has not received approval as a pharmaceutical. Banned by WADA.

Important

Sold as a research-purpose product. For any medical questions, please consult a physician.

← Back to catalog